WuXi Biologics (Cayman) Inc. (HKG:2269)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
41.96
-0.04 (-0.10%)
Oct 8, 2025, 2:45 PM HKT

Revenue by Product

Millions HKD. Fiscal year is Jan - Dec.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2014 - 2019
Biologics
15.97B
Log In
Log In
Log In
Log In
Upgrade
Biologics Growth
-4.45%
Log In
Log In
Log In
Log In
Upgrade
XDC
4.28B
Log In
Log In
Log In
Log In
Upgrade
XDC Growth
103.02%
Log In
Log In
Log In
Log In
Upgrade
Research Services on Fee-for-Service
-
Log In
Log In
Log In
Log In
Upgrade
Research Services on Fee-for-Service Growth
-
Log In
Log In
Log In
Log In
Upgrade
Research Services on Full-Time-Equivalent
-
Log In
Log In
Log In
Log In
Upgrade
Research Services on Full-Time-Equivalent Growth
-
Log In
Log In
Log In
Log In
Upgrade
Project Management Organization Services
-
Log In
Log In
Log In
Log In
Upgrade
Project Management Organization Services Growth
-
Log In
Log In
Log In
Log In
Upgrade
Commercial Manufacturing Contracts
-
Log In
Log In
Log In
Log In
Upgrade
Commercial Manufacturing Contracts Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other Biologics Products
-
Log In
Log In
Log In
Log In
Upgrade
Other Biologics Products Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions HKD. Fiscal year is Jan - Dec.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2014 - 2019
North America
11.60B
Log In
Log In
Log In
Log In
Upgrade
North America Growth
29.99%
Log In
Log In
Log In
Log In
Upgrade
Europe
4.69B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
-17.49%
Log In
Log In
Log In
Log In
Upgrade
China
3.06B
Log In
Log In
Log In
Log In
Upgrade
China Growth
-11.34%
Log In
Log In
Log In
Log In
Upgrade
Rest of the World
906.79M
Log In
Log In
Log In
Log In
Upgrade
Rest of the World Growth
17.49%
Log In
Log In
Log In
Log In
Upgrade